FD
FS Development Corp. II
Venture Capital
SPAC sponsored by Foresite Capital that merged with Pardes Biosciences in 2022, creating a public biopharma company developing oral antiviral drugs for SARS-CoV-2.
San Francisco · 1+ investments · 1 portfolio companies
Biotech
- Headquarters
- San Francisco
- Portfolio Company
- 1
- Total Investment
- 1
- Last Investment
- Dec 2021
- Geographic Focus
- United States
Investment Thesis
Formed to identify and merge with a promising biotech/life-sciences company; targeted Pardes Biosciences to advance oral antiviral treatment and prevention of SARS-CoV-2 infections.
FS Development Corp. II is a Venture Capital firm based in San Francisco. It has made 1 investment in Biotech, including Pardes Biosciences.
Portfolio1
Co-investors3
Sign up to view co-investors
3 co-investors across 3 shared portfolio companies — who they back alongside, and how often they lead.
Venture Capital ×2 · Private Equity ×1 · 1 shared rounds
Investment History
Sign up to view investment history
Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.
Your firm? Embed this profile
Add the live badge to your site — it stays current as your portfolio data updates.
<a href="https://indexed.vc/investors/fs-development-corp-ii"><img src="https://indexed.vc/api/badge/investor/fs-development-corp-ii" alt="FS Development Corp. II on Indexed.vc" width="260" height="76" /></a>